Just when you thought it might be over.
Well just when you think one thing another happens. Medtronic made it official acquiring patch pump maker EOFlow for a whopping $738 million. Keep in mind while approved overseas the system while submitted to the FDA is not yet approved. This move has huge ramifications and not just for Medtronic so let’s have at it.
1. Shares of Insulet are down on the news – BUY now. There is no way the EOFlow now in the hands of Medtronic will hurt sales of the Omnipod 5 and could actually help sales. Plus look for Insulet to use that IP . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.